A study published by Caris showed that certain tumor types had very low or no HER2 overexpression, which has implications for biomarker testing strategies.

North Texas is packing a new public company in the online space for guns– and it comes with an assist from Donald Trump Jr.

The largest trade of the day was ARK’s purchase of 115,380 shares of electric vehicle giant Tesla Inc, split between its ARKK ...

Waters and BD will merge biosciences and diagnostics in a $17.5B deal via Reverse Morris Trust, creating a life sciences ...

Carlsmed Inc. launched its IPO at a price of $14 to $16 per share for 6.7 million shares, which would raise just over $100.5 ...

Waters Corporation is merging with BD’s Biosciences and Diagnostic Solutions business in a $17.5 billion deal to expand its capabilities in life sciences and diagnostics.

As the U.S. stock market experiences mixed movements with major indexes reaching record highs amidst inflation data and earnings reports, the tech sector stands out with notable rallies spurred by ...

DOGE cuts are leading to new warnings in filings from biotech and health-care companies looking to IPO stateside. The big ...

On the buy side, ARK’s ARKG ETF invested in Caris Life Sciences Inc (PRIVATE:CAI), purchasing 52,527 shares with a total dollar value of $1,392,490. This move marks a new investment direction for the ...

Cedar Park officials are in the early stages of seeking partners to build a mixed-used development with space devoted to the ...

However, Waters has announced plans to merge with BD's life science and diagnostics segment in early 2026, which will dilute that interest in that highly regulated end market, going forward. The ...